EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy

Shi Han, Linghui Zhou, Haiqiong Zheng, Yi Zhao, Zhen Cai, Jingsong He, Xiujin Ye, Wenjun Wu, Jie Sun, Weiyan Zheng, Guoqing Wei, Li Yu und 6 weitere

Annals of Hematology · 03.06.2026 · 105 (8)

DOI: 10.1007/s00277-026-07085-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 03.06.2026. Verfasst von Shi Han und 17 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Roa…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanming Project of Medicine in Shenzhen, the Zhejiang Provincial Department of Science and Technology "Jianbing Lingyan+X" Research and Development Project Plan, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsLymphoma, Large B-Cell, DiffuseMutationAdultAgedFemaleHumansMaleMiddle AgedAntibodies, Monoclonal, Murine-DerivedChinaCyclophosphamideDoxorubicinGenomicsPrednisonePrognosisRituximabVincristineEast Asian People

Stichwörter der Autor:innen

Deoxyribonucleic acid detectionDiffuse large B-cell lymphomaGenomic biomarkersPrognosisRelapse risk

Substanzen

Antibodies, Monoclonal, Murine-DerivedCyclophosphamideDoxorubicinPrednisoneR-CHOP protocolRituximabVincristine

Autor:innen und Institutionen

  • Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310000, China.
  • Institute of Hematology, Zhejiang University, Hangzhou, 310000, China.
  • Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, 310000, China.
  • Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center of Shenzhen University, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518000, China.
  • Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310000, China. 1313016@zju.edu.cn.
  • Institute of Hematology, Zhejiang University, Hangzhou, 310000, China. 1313016@zju.edu.cn.

Förderung

  • Sanming Project of Medicine in Shenzhen
  • the Zhejiang Provincial Department of Science and Technology "Jianbing Lingyan+X" Research and Development Project Plan
  • National Natural Science Foundation of China
  • the National Science Fund for Distinguished Young Scholars
  • the Zhejiang Provincial Department of Science and Technology “Jianbing Lingyan+X” Research and Development Project Plan

Zitieren

APA

Han, S., Zhou, L., Zheng, H., Zhao, Y., Cai, Z., He, J., Ye, X., Wu, W., Sun, J., Zheng, W., Wei, G., Yu, L., Wang, L., Gao, K., Yue, J., Zhang, M., Hu, Y., & Huang, H. (2026). Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy. Annals of Hematology, 105(8). https://doi.org/10.1007/s00277-026-07085-y

Vancouver

Han S, Zhou L, Zheng H, Zhao Y, Cai Z, He J, et al. Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy. Annals of Hematology. 2026;105(8). doi:10.1007/s00277-026-07085-y

BibTeX
@article{Han2026,
  author = {Han, Shi and Zhou, Linghui and Zheng, Haiqiong and Zhao, Yi and Cai, Zhen and He, Jingsong and Ye, Xiujin and Wu, Wenjun and Sun, Jie and Zheng, Weiyan and Wei, Guoqing and Yu, Li and Wang, Lixin and Gao, Ke and Yue, Juan and Zhang, Mingming and Hu, Yongxian and Huang, He},
  title = {Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {8},
  doi = {10.1007/s00277-026-07085-y}
}
Kostenlos starten →